Telos Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Telos Capital Management's EW Position: Q3 2026 in Review
Telos Capital Management increased its Edwards Lifesciences (EW) stake by 2.2% in Q3 2026, buying an estimated $161K and bringing the position to 84,626 shares worth $7.3M. The position accounts for 0.64% of the portfolio, ranked #52.
Telos Capital Management first reported a position in EW in Q2 2023 and has held it in 14 quarters since. The position peaked at $9.11M in Q1 2024. 1,342 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Telos Capital Management held 84,626 shares of Edwards Lifesciences worth $7.3M as of Q3 2026.
- Telos Capital Management bought 1,815 Edwards Lifesciences shares in Q3 2026, an estimated $161K.
- Edwards Lifesciences made up 0.64% of Telos Capital Management's portfolio in Q3 2026, its #52 holding.
- Telos Capital Management first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 14 quarters since.
- Telos Capital Management's Edwards Lifesciences position peaked at $9.11M in Q1 2024.
- 1,342 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Telos Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.